Chromadex Corp Stock In The News

CDXC Stock  USD 7.44  0.19  2.49%   
Our overall analysis of Chromadex Corp's news coverage and content from conventional and social sources shows investors' bearish mood towards Chromadex Corp. The specific impact of Chromadex Corp news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Chromadex Corp's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Chromadex Corp headlines in addition to utilizing other, more conventional financial analysis modules. Check out Chromadex Corp Backtesting and Chromadex Corp Hype Analysis.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.

Chromadex Corp Today Top News and Investor Outlook

Yahoo News
ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference
https://finance.yahoo.com/news/chromadex-present-lytham-partners-2024-210800635.html
 Bullish
Yahoo News
ChromaDex Corporation's (NASDAQ:CDXC) Shift From Loss To Profit
https://finance.yahoo.com/news/chromadex-corporations-nasdaq-cdxc-shift-134053351.html
 Bullish
Yahoo News
ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®
https://finance.yahoo.com/news/chromadex-supports-us-military-industry-140400552.html
 Bullish
Yahoo News
Neurohacker Collective and ChromaDex Partner to Optimize Cellular Health with the Debut of Qualia NAD+
https://finance.yahoo.com/news/neurohacker-collective-chromadex-partner-optimize-153000090.html
 Bullish
Yahoo News
A Milestone Phase I Randomized, Double-B...
https://finance.yahoo.com/news/milestone-phase-randomized-double-blind-133400717.html
 Neutral
Yahoo News
An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 44% Undervalued
https://finance.yahoo.com/news/intrinsic-calculation-chromadex-corporation-nasdaq-103836202.html
 Bullish
Yahoo News
Newly Published Phase II Clinical Study ...
https://finance.yahoo.com/news/newly-published-phase-ii-clinical-133200719.html
 Neutral
Yahoo News
ChromaDex Corporation (NASDAQ:CDXC) Q3 2023 Earnings Call Transcript
https://finance.yahoo.com/news/chromadex-corporation-nasdaq-cdxc-q3-175450934.html
 Bullish
Yahoo News
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, November 14, 2023
https://finance.yahoo.com/news/chromadex-participate-renmark-virtual-non-133200440.html
 Bullish
Yahoo News
ChromaDex Corp (CDXC) Reports Growth in Net Sales and Positive Adjusted EBITDA in Q3 2023
https://finance.yahoo.com/news/chromadex-corp-cdxc-reports-growth-233332937.html
 Bullish

Chromadex Corp Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Chromadex and other traded companies coverage with news coverage. We help investors stay connected with Chromadex headlines for the 23rd of November to make an informed investment decision based on correlating the impacts of news items on Chromadex Stock performance. Please note that trading solely based on the Chromadex Corp hype is not for everyone as timely availability and quick action are needed to avoid losses.
Chromadex Corp's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Chromadex Corp investors visualize upcoming and past events in order to time the market based on Chromadex Corp noise-free hype analysis.
Chromadex Corp stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Chromadex earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Chromadex Corp that are available to investors today. That information is available publicly through Chromadex media outlets and privately through word of mouth or via Chromadex internal channels. However, regardless of the origin, that massive amount of Chromadex data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Chromadex Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Chromadex Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Chromadex Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Chromadex Corp alpha.

Chromadex Largest EPS Surprises

Earnings surprises can significantly impact Chromadex Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-10-31
2024-09-300.010.020.01100 
2024-05-08
2024-03-31-0.02-0.010.0150 
2023-08-09
2023-06-30-0.04-0.030.0125 
2022-08-10
2022-06-30-0.08-0.09-0.0112 
2021-03-10
2020-12-31-0.09-0.1-0.0111 
2024-08-07
2024-06-30-0.02-2.0E-40.019899 
View All Earnings Estimates

Chromadex Corp Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Chromadex Corp Stock. Current markets are strongly bullish. About 89% of major world exchanges and indexes are currently up. See today's market update for more information.
Investing News at Macroaxis
21st of November 2024
Disposition of 82734 shares by Lee Jeong James of Chromadex Corp at 1.52 subject to Rule 1...
at investing.com 
Simply Wall St News at Macroaxis
19th of November 2024
Disposition of 82734 shares by Lee Jeong James of Chromadex Corp at 1.52 subject to Rule 1...
at simplywall.st 
businesswire News
14th of November 2024
ChromaDexs Patented Nicotinamide Riboside Ingredient, Niagen, Featured as the Hero Ingredi...
at businesswire.com 
Macroaxis News
12th of November 2024
Disposition of 82734 shares by Lee Jeong James of Chromadex Corp at 1.52 subject to Rule 1...
at MacroaxisInsider 
Yahoo News
8th of November 2024
What Makes ChromaDex a Strong Momentum Stock Buy Now
at finance.yahoo.com 
Simply Wall St News at Macroaxis
7th of November 2024
ChromaDexs Solid Earnings Are Supported By Other Strong Factors
at simplywall.st 
Gurufocus Stories at Macroaxis
1st of November 2024
Disposition of 82734 shares by Lee Jeong James of Chromadex Corp at 1.52 subject to Rule 1...
at gurufocus.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chromadex Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chromadex Corp's short interest history, or implied volatility extrapolated from Chromadex Corp options trading.
When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock:
Check out Chromadex Corp Backtesting and Chromadex Corp Hype Analysis.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.02
Revenue Per Share
1.215
Quarterly Revenue Growth
0.312
Return On Assets
0.0051
Return On Equity
0.0482
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.